Cerasorb®

Use for specific indications

Traumatology / orthopaedics

Fractures, tumors or inflammatory diseases cause bone defects the treatment of which still pose a great challenge to orthopaedists and trauma surgeons. Often, these defects must be filled with bone material. Joint fusions particularly in spinal surgery - require bone material, as well.

Autologous bone is still the standard choice of defect filling material for many indications. The advantage of its osteoinductivity is opposed by the risks of primary and secondary consequential complications connected with a second surgery required for bone harvesting.

CERASORB, the synthetic resorbable bone regeneration material is an alternative to autologous bone grafting. The extent, duration and complication rate of defect filling procedures can be reduced, and the resorption and simultaneous formation of vital autologous bone results in 'restituio ad integrum'.

Safe and easy handling is a particular clinical advantage. CERASORB intermixes with the patient's blood to form a paste that allows the defect to be filled level.

The interconnecting micropore structure permits the rapid penetration of CERASORB while its mechanical stability is high enough to prevent premature disintegration into micro particles caused by macrophage activity.

It is now possible and in the patient's best interest - to accelerate bone regeneration by systematically utilizing growth factors. In 2000, CERASORB became the first synthetic carrier material for patient Platelet Rich Plasma (thrombocyte concentrate) to be certified in Europe.

CERASORB has been successfully used in the following areas of indication:

  • Distal radial fractures
  • Bone cysts
  • Spine surgery
  • Hand surgery
  • Acetabular revision

Product variations

  • Cerasorb M
  • Cerasorb block forms